Sun Pharmaceutical Medicare Limited - Company Profile

It is a pharma public limited company based in Vadodara, Gujarat, India, established in 2017.

2017 Vadodara, Gujarat, India Amalgamated

Last Updated: January 06, 2026

About Sun Pharmaceutical Medicare Limited

Sun Pharmaceutical Medicare Limited, a amalgamated public limited company, was established on 16 January 2017 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U36900GJ2017PLC095132. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Employing 915 professional, Its leadership includes Rakeshchandra Jagdishprasad Sinha (Director), Prince Kalarickal Elias (Director), Kedar Nath Senapati (Director). Past directors included Sailesh Trambaklal Desai, Ashok Indulal Bhuta, Suresh Kumar Ajmera. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sparc, Tandalja,, Vadodara, Gujarat, 390012.

Company Details

CIN/LLPIN
U36900GJ2017PLC095132
Registration Number
095132
Incorporation Date
16 January 2017
Authorized Capital
₹2.50 M
Paid-Up Capital
₹2.50 M
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Amalgamated

Key Metrics

Authorised Capital ₹ 2.50 M as on 06-01-2026
Paid Up Capital ₹ 2.50 M as on 06-01-2026
Company Age 9 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 8.98% (FY 2023)
Profit Growth **** -134.13% (FY 2023)
Ebitda **** 1.70% (FY 2023)
Net Worth -15.00% (FY 2023)
Total Assets **** 58.98% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Sun Pharmaceutical Medicare Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sun Pharmaceutical Medicare Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rakeshchandra Jagdishprasad Sinha	Director	19 Apr 2019	Current
Prince Kalarickal Elias	Director	29 Mar 2024	Current
Kedar Nath Senapati	Director	29 Jan 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	31 Mar 2024	Past
Pramod Abcsdd	Director	30 Jan 2024	Past
Pramod Abcsdd	Director	03 May 2019	Past
Pramod Abcsdd	Additional Director	30 Sep 2019	Past
Pramod Abcsdd	Additional Director	26 Sep 2024	Past
Pramod Abcsdd	Director	15 Apr 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sun Pharmaceutical Medicare.

Sun Pharmaceutical Medicare Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.98% increase. The company also saw a substantial fall in profitability, with a 134.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

8.98%

*******

Revenue from Operations

*******

8.01%

*******

Total Assets

*******

58.98%

*******

Profit or Loss

*******

-134.13%

*******

Net Worth

*******

-15.00%

*******

EBITDA

*******

1.70%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sun Pharmaceutical Medicare?

In 2023, Sun Pharmaceutical Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sun Pharmaceutical Medicare?

Sun Pharmaceutical Medicare has a workforce of 915 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sun Pharmaceutical Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharmaceutical Medicare's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sun Pharmaceutical Medicare

Recent Activity within the Organization

Annual General Meeting

Sun Pharmaceutical Medicare Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
29 Sep 2025
Balance Sheet

Sun Pharmaceutical Medicare Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
31 Mar 2025
Director Appointment

Prince Kalarickal Elias was appointed as a Director was appointed as a Director on 29 Mar 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
29 Mar 2024
Director Appointment

The activity Kedar Nath Senapati was appointed as a Director was appointed as a Director on 29 Jan 2024 & has been associated with this company since 2 years 2 months . was completed.
29 Jan 2024
Director Appointment

Progress on Rakeshchandra Jagdishprasad Sinha was appointed as a Director was appointed as a Director on 19 Apr 2019 & has been associated with this company since 6 years 11 months . was documented.
19 Apr 2019
Company Incorporation

The activity Sun Pharmaceutical Medicare Limited was registered on 16 Jan 2017 with Roc Ahmedabad & aged 9 years 2 months as per MCA records. was completed.
16 Jan 2017

Explore recent activity and updates - View Recent Activity